Respiratory infections and asthma.

Airway responsiveness is increased during respiratory virus infections, both in subjects with asthma and without underlying pulmonary disease. Furthermore, the airway hyperresponsiveness is altered for a prolonged period of time, weeks or months after the viral illness has subsided. This article reviews the possible mechanisms of virus-associated airway hyperresponsiveness, including the complex interplay of IgE-dependent reactions, changes in autonomic nervous system function and inflammation, epithelial damage, effects of viruses on the cellular immune response, and enhanced late-phase response.

[1]  W. Jusko,et al.  Steroid dose sparing: pharmacodynamic responses to single versus divided doses of methylprednisolone in man. , 1990, The Journal of allergy and clinical immunology.

[2]  A. Kagey‐Sobotka,et al.  Cutaneous late-phase response to allergen. Mediator release and inflammatory cell infiltration. , 1989, The Journal of clinical investigation.

[3]  I. Tager.  Epidemiology of Respiratory Infections in the Development of Airway Hyperreactivity , 1990 .

[4]  S. Baron,et al.  Role of interferon in leukocyte histamine release caused by common respiratory viruses. , 1988, The Journal of infectious diseases.

[5]  D. McDonald.  Respiratory tract infections increase susceptibility to neurogenic inflammation in the rat trachea. , 1988, The American review of respiratory disease.

[6]  P. Ogra,et al.  The appearance of cell-bound IgE in respiratory-tract epithelium after respiratory-syncytial-virus infection. , 1980, The New England journal of medicine.

[7]  N. Flavahan,et al.  The Respiratory Epithelium Releases a Smooth Muscle Relaxing Factor , 1985 .

[8]  A. Notkins,et al.  Enhancement of IgE-mediated histamine release from human basophils by viruses: role of interferon , 1977, The Journal of experimental medicine.

[9]  F. Sánchez‐Madrid,et al.  The functional significance, distribution, and structure of LFA-1, LFA-2, and LFA-3: cell surface antigens associated with CTL-target interactions. , 1983, Journal of immunology.

[10]  J. D. Capra,et al.  Monoclonal antibodies to immunoglobulin G4 induce histamine release from human basophils in vitro. , 1982, The Journal of allergy and clinical immunology.

[11]  D. Hahn,et al.  Association of Chlamydia pneumoniae (strain TWAR) infection with wheezing, asthmatic bronchitis, and adult-onset asthma. , 1991, JAMA.

[12]  P. Barnes.  ASTHMA AS AN AXON REFLEX , 1986, The Lancet.

[13]  A. Mcclelland,et al.  The major human rhinovirus receptor is ICAM-1 , 1989, Cell.

[14]  W. Busse.  Decreased granulocyte response to isoproterenol in asthma during upper respiratory infections. , 2015, The American review of respiratory disease.

[15]  W. Busse,et al.  Effect of influenza A virus on leukocyte histamine release. , 1983, The Journal of allergy and clinical immunology.

[16]  D. Littman,et al.  Viral receptors of the immunoglobulin superfamily , 1989, Cell.

[17]  P. Ogra,et al.  Predictive value of respiratory syncytial virus-specific IgE responses for recurrent wheezing following bronchiolitis. , 1986, The Journal of pediatrics.

[18]  K. Mcintosh,et al.  The association of viral and bacterial respiratory infections with exacerbations of wheezing in young asthmatic children+ , 1973, The Journal of Pediatrics.

[19]  D. Wong,et al.  Parainfluenza virus bronchiolitis. Epidemiology and pathogenesis. , 1986, American journal of diseases of children.

[20]  B. Bierer,et al.  T cell adhesion molecules , 1988, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[21]  J. Nadel,et al.  Mechanisms of bronchial hyperreactivity in normal subjects after upper respiratory tract infection. , 1976, The American review of respiratory disease.

[22]  J. Nadel,et al.  Influenza infection causes airway hyperresponsiveness by decreasing enkephalinase. , 1988, Journal of applied physiology.

[23]  D. Wong,et al.  The development of respiratory syncytial virus-specific IgE and the release of histamine in nasopharyngeal secretions after infection. , 1981, The New England journal of medicine.

[24]  J. Nadel,et al.  Virus induces airway hyperresponsiveness to tachykinins: role of neutral endopeptidase. , 1989, Journal of applied physiology.

[25]  J. Hooks,et al.  Enhancement of basophil chemotaxis in vitro by virus-induced interferon. , 1981, The Journal of clinical investigation.

[26]  R. Slavin,et al.  Sinusitis and bronchial asthma. , 1980, The Journal of allergy and clinical immunology.

[27]  H. Gruber,et al.  Ribavirin inhibits mast cell mediator release. , 1987, The Journal of pharmacology and experimental therapeutics.

[28]  W. Liu,et al.  Immunomodulation of influenza virus infection in the precipitating asthma attack. , 1988, Chest.

[29]  W. Busse,et al.  Parainfluenza 3 infection blocks the ability of a beta adrenergic receptor agonist to inhibit antigen-induced contraction of guinea pig isolated airway smooth muscle. , 1981, The Journal of clinical investigation.

[30]  B. Ames,et al.  Oxygen radicals and human disease. , 1987, Annals of internal medicine.

[31]  E. Walsh,et al.  Aerosolized ribavirin treatment of infants with respiratory syncytial viral infection. A randomized double-blind study. , 1983, The New England journal of medicine.

[32]  V. Knight,et al.  Selective inhibition of functional lymphocyte subpopulations by ribavirin , 1982, Antimicrobial Agents and Chemotherapy.

[33]  A. Szentivanyi.  The beta adrenergic theory of the atopic abnormality in bronchial asthma , 1968 .

[34]  R. Rothlein,et al.  Intercellular adhesion molecule-1 (ICAM-1) in the pathogenesis of asthma. , 1990, Science.

[35]  W. Busse,et al.  In vitro incubation with influenza virus primes human polymorphonuclear leukocyte generation of superoxide. , 1991, American journal of respiratory cell and molecular biology.

[36]  A. Fryer,et al.  Parainfluenza virus type 1 reduces the affinity of agonists for muscarinic receptors in guinea-pig lung and heart. , 1990, European journal of pharmacology.

[37]  P. Vanhoutte.  Epithelium-derived relaxing factor(s) and bronchial reactivity. , 1989, The Journal of allergy and clinical immunology.

[38]  G. Rachelefsky,et al.  Chronic sinus disease with associated reactive airway disease in children. , 1984, Pediatrics.

[39]  D. Staunton,et al.  A cell adhesion molecule, ICAM-1, is the major surface receptor for rhinoviruses , 1989, Cell.

[40]  E. Bleecker,et al.  Immediate and late inflammatory responses to ragweed antigen challenge of the peripheral airways in allergic asthmatics. Cellular, mediator, and permeability changes. , 1991, The American review of respiratory disease.

[41]  P. Suratt,et al.  Exacerbations of asthma in adults during experimental rhinovirus infection. , 1985, The American review of respiratory disease.

[42]  B. Volovitz,et al.  The Release of Leukotrienes in the Respiratory Tract during Infection with Respiratory Syncytial Virus: Role in Obstructive Airway Disease , 1988, Pediatric Research.

[43]  C. Reed,et al.  Viruses as precipitants of asthmatic attacks in children. , 1974, JAMA.

[44]  E. Goetzl,et al.  Predominant generation of 15-lipoxygenase metabolites of arachidonic acid by epithelial cells from human trachea. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[45]  P. Edelson,et al.  Effect of ribavirin therapy on respiratory syncytial virus-specific IgE and IgA responses after infection. , 1987, The Journal of infectious diseases.

[46]  D. Staunton,et al.  A soluble form of intercellular adhesion molecule-1 inhibits rhinovirus infection , 1990, Nature.

[47]  E. Dick,et al.  Enhancement by parainfluenza 3 infection of contractile responses to substance P and capsaicin in airway smooth muscle from the guinea pig. , 1987, The American review of respiratory disease.

[48]  P. Barnes.  Neuropeptides in the lung: localization, function, and pathophysiologic implications. , 1987, The Journal of allergy and clinical immunology.

[49]  Elliot,et al.  Rhinovirus upper respiratory infection increases airway hyperreactivity and late asthmatic reactions. , 1989, The Journal of clinical investigation.

[50]  A. Togias,et al.  Inflammatory mediators in late antigen-induced rhinitis. , 1985, The New England journal of medicine.